You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkin Disease

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

Not yet recruiting
  • Hodgkin Lymphoma
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Aug 18, 2022

Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Charlottesville, Virginia
    University of Virginia
Jul 27, 2022

Classic Hodgkin's Lymphoma Trial in Beijing (Sintilimab, Carboplatin, Etoposide)

Recruiting
  • Classic Hodgkin's Lymphoma
  • Sintilimab
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 12, 2022

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in

Completed
  • Hodgkin's Disease
    • Louisville, Kentucky
      Norton Cancer Institute
    Dec 14, 2021

    Hodgkin Lymphoma Trial (pembrolizumab)

    Active, not recruiting
    • Hodgkin Lymphoma
    • pembrolizumab
    • (no location specified)
    May 30, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Chapel Hill (Nivolumab, Pembrolizumab)

    Recruiting
    • Relapsed Hodgkin Lymphoma
    • Refractory Hodgkin Lymphoma
    • Nivolumab
    • Pembrolizumab
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Jul 22, 2022

    Hodgkin Lymphoma Trial in Cologne (B-CAP, Brentuximab Vedotin)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Cologne, Germany
      1st Dept. of Medicine, Cologne University Hospital
    Aug 5, 2022

    Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

    Recruiting
    • Lymphoma
    • +3 more
    • New York, New York
      Columbia University
    Apr 27, 2022

    Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

    Recruiting
    • Hodgkin Lymphoma
    • +3 more
    • Stanford, California
      Stanford University
    Jun 21, 2022

    Hodgkin Lymphoma Trial in New York (Mocetinostat Plus Brentuximab Vedotin)

    Completed
    Has Results
    • Hodgkin Lymphoma
    • Mocetinostat Plus Brentuximab Vedotin
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 10, 2022

    Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

    Completed
    Has Results
    • Hodgkin Lymphoma
    • Diffuse Large B-Cell Lymphoma
    • Campath
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 11, 2022

    Hodgkin Lymphoma, Lung Cancer Trial in Manchester (Low dose CT thorax)

    Enrolling by invitation
    • Hodgkin Lymphoma
    • Lung Cancer
    • Low dose CT thorax
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Mar 10, 2022

    Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated

    Completed
    • Hodgkin's Lymphoma
    • Cardiac Magnetic Resonance Imaging
    • Echocardiogram
    • Jacksonville, Florida
      University of Florida Health Proton Therapy Institute
    Jun 9, 2022

    Hodgkin Lymphoma Trial in Italy (Tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Alessandria, IT, Italy
    • +9 more
    Aug 4, 2023

    Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

    Not yet recruiting
    • Relapsed or Refractory Hodgkin Lymphoma
    • Peripheral T Cell Lymphoma
    • (no location specified)
    May 30, 2023

    Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

    Recruiting
    • Hodgkins Lymphoma
    • Non Hodgkins Lymphoma
    • TAA-specific CTLs
    • Houston, Texas
      Texas Children's Hospital
    Jul 14, 2022

    Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

    Recruiting
    • Hodgkin's Lymphoma
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 5, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

    Recruiting
    • Acute Myelogenous Leukemia
    • +4 more
    • Stem cell transplantation
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 23, 2022

    Hodgkin Lymphoma Trial in Guadalajara (Pentoxifylline, Placebo)

    Recruiting
    • Hodgkin Lymphoma
    • Guadalajara, Jalisco, Mexico
      Hospital Civil de Guadalajara Fray Antonio Alcalde
    Aug 4, 2022

    Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

    Recruiting
    • Lymphoma
    • +4 more
    • Pharmacokinetics
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 12, 2022

    Hodgkin Lymphoma, Adolescent Behavior, Chemo Effect Trial (Description of therapeutical results)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Description of therapeutical results
    • (no location specified)
    Dec 15, 2022

    Hodgkin Lymphoma Trial (Gemcitabine, Dexamethasone, Cisplatin)

    Not yet recruiting
    • Hodgkin Lymphoma
    • (no location specified)
    May 9, 2022

    Advanced Classical Hodgkin's Lymphoma in Brazil Treated With

    Not yet recruiting
    • Hodgkin Lymphoma
    • No Intervention
    • Salvador, Bahia, Brazil
    • +5 more
    Oct 23, 2023

    HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

    Active, not recruiting
    • HIV Infection
    • +3 more
    • brentuximab vedotin
    • +3 more
    • Clamart, France
    • +5 more
    Aug 11, 2022